Resultats de la cerca - Habra, Mouhammed
- Mostrar 1 - 20 resultats de 51
- Anar a la pàgina següent
-
1
-
2
-
3
-
4
-
5
Response to Letter to the Editor From Berruti et al: “Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients’ Survival” per Srougi, Victor, Habra, Mouhammed A, Fragoso, Maria C B V
Publicat 2022Text -
6
-
7
-
8
A Durable Response With the Combination of Nivolumab and Cabozantinib in a Patient With Metastatic Paraganglioma: A Case Report and Review of the Current Literature per Economides, Minas P., Shah, Amishi Y., Jimenez, Camilo, Habra, Mouhammed A., Desai, Monica, Campbell, Matthew T.
Publicat 2020Text -
9
-
10
Imaging characteristics of pathologically proven adrenal adenomas with myelolipomatous degeneration: correlation with clinical and pathologic features per Guccione, Jeffrey, Soliman, Moataz, Zhang, Miao, Habra, Mouhammed Amir, Collins, Katrina, Zhao, Jianping, Elsayes, Khaled M
Publicat 2022Text -
11
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW ON THE EVALUATION AND MANAGEMENT OF ADRENOCORTICAL CARCINOMA IN AN ADULT: A PRACTICAL APPROACH per Kiseljak-Vassiliades, Katja, Bancos, Irina, Hamrahian, Amir, Habra, Mouhammed Amir, Vaidya, Anand, Levine, Alice C., Else, Tobias
Publicat 2020Text -
12
[(18)F]Fluorodeoxyglucose Positron Emission Tomography–Guided Therapy in Metastatic Adrenocortical Carcinoma: An Illustrative Case per Chuang, Hubert H., Deniz, Ferhat, Sircar, Kanishka, Jimenez, Camilo, Rubin De Celis, Carlos, Wood, Christopher G., Habra, Mouhammed Amir
Publicat 2012Text -
13
Endocrine and Neuroendocrine Tumors Special Issue—Checkpoint Inhibitors for Adrenocortical Carcinoma and Metastatic Pheochromocytoma and Paraganglioma: Do They Work? per Jimenez, Camilo, Armaiz-Pena, Gustavo, Dahia, Patricia L. M., Lu, Yang, Toledo, Rodrigo A., Varghese, Jeena, Habra, Mouhammed Amir
Publicat 2022Text -
14
Relacorilant With Pembrolizumab: A Phase 1b, Open-Label Study of a Selective Glucocorticoid Receptor Modulator Combined With a Checkpoint Inhibitor for Patients With Adrenocortical... per Habra, Mouhammed Amir, Hammer, Gary D, Kebebew, Electron, Worden, Francis P, Raj, Nitya, Hallanger-Johnson, Julie E, Grauer, Andreas, Moraitis, Andreas
Publicat 2021Text -
15
-
16
The Clinical Impact of [(68)Ga]-DOTATATE PET/CT for the Diagnosis and Management of Ectopic Adrenocorticotropic Hormone – Secreting Tumors per Wannachalee, Taweesak, Turcu, Adina F., Bancos, Irina, Habra, Mouhammed Amir, Avram, Anca M., Chuang, Hubert H., Waguespack, Steven G., Auchus, Richard J.
Publicat 2019Text -
17
SAT-175 Trial in Progress Interim Report: A Phase II Clinical Trial Using Single Agent Cabozantinib in Advanced Adrenocortical Carcinoma per Bedrose, Sara Shokry Daniel, Altameemi, Lina, Daher, Marilyne, De Rosa, Gina Tamsen, Varghese, Jeena Mary, Jimenez, Camilo, Campbell, Matthew, Habra, Mouhammed Amir
Publicat 2020Text -
18
Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort study per Kimpel, Otilia, Bedrose, Sara, Megerle, Felix, Berruti, Alfredo, Terzolo, Massimo, Kroiss, Matthias, Mai, Knut, Dekkers, Olaf M., Habra, Mouhammed Amir, Fassnacht, Martin
Publicat 2021Text -
19
Clinical Benefits of Systemic Chemotherapy for Patients with Metastatic Pheochromocytomas or Sympathetic Extra-Adrenal Paragangliomas: Insights from the Largest Single Institutiona... per Ayala-Ramirez, Montserrat, Feng, Lei, Habra, Mouhammed A., Rich, Thereasa, Dickson, Paxton V., Perrier, Nancy, Phan, Alexandria, Waguespack, Steven, Patel, Shreyaskumar, Jimenez, Camilo
Publicat 2011Text -
20
Bone Metastases and Skeletal-Related Events in Patients With Malignant Pheochromocytoma and Sympathetic Paraganglioma per Ayala-Ramirez, Montserrat, Palmer, J. Lynn, Hofmann, Marie-Claude, de la Cruz, Maxine, Moon, Bryan S., Waguespack, Steven G., Habra, Mouhammed Amir, Jimenez, Camilo
Publicat 2013Text